Trifluoroacetamide

Trifluoroacetamide

SCHEMBL1007195

C#CCN.NC(=O)C(F)(F)F

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
OR51E2 Q9H255 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL27947517 0.84 HRH4 (0.33) OR51E2
Trifluoroacetamide SCHEMBL15993978 0.80 LMNA (0.50) ALDH1A1LMNAOR51E2TDP1
Trifluoroacetamide SCHEMBL20137335 0.77 HDAC6 (0.35) ALDH1A1LMNAOR51E2TDP1
Trifluoroacetamide SCHEMBL28877296 0.77 HDAC6 (0.35) ALDH1A1LMNAOR51E2TDP1
Trifluoroacetamide SCHEMBL15993858 0.76 LMNA (0.46) ALDH1A1LMNAOR51E2TDP1
Trifluoroacetamide SCHEMBL8526109 0.76
Trifluoroacetamide SCHEMBL142 0.76
Trifluoroacetamide SCHEMBL27678123 0.76 LMNA (0.42) ALDH1A1LMNAOR51E2TDP1
Trifluoroacetamide SCHEMBL11793075 0.73
Trifluoroacetamide SCHEMBL5638451 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9803240-B2 Stabilized nucleic acid dark quencher-fluorophore probes BIOSEARCH TECHNOLOGIES, INC. (US) 2017-10-31 US disclosed
EP-2757091-B1 Stabilized Nucleic Acid Dark Quencher-Fluorophore Probes BIOSEARCH TECH INC (US) 2017-06-28 EP disclosed
EP-2757091-A1 Stabilized Nucleic Acid Dark Quencher-Fluorophore Probes Biosearch Technologies, Inc. (US) 2014-07-23 EP disclosed
US-20140194611-A1 STABILIZED NUCLEIC ACID DARK QUENCHER-FLUOROPHORE PROBES BIOSEARCH TECHNOLOGIES, INC. (US) 2014-07-10 US disclosed
US-8674094-B2 Stabilized nucleic acid dark quencher-fluorophore probes BIOSEARCH TECHNOLOGIES, INC. (US) 2014-03-18 US disclosed
CN-102037144-B Stabilized nucleic acid dark quencher-fluorophore probes BIOSEARCH TECHNOLOGIES INC 2013-09-25 CN disclosed
US-8466266-B2 Stabilized nucleic acid dark quencher-fluorophore probes BIOSEARCH TECHNOLOGIES, INC. (US) 2013-06-18 US disclosed
US-20110282041-A1 STABILIZED NUCLEIC ACID DARK QUENCHER-FLUOROPHORE PROBES BIOSEARCH TECHNOLOGIES, INC. (US) 2011-11-17 US disclosed
CN-102037144-A Stabilized nucleic acid dark quencher-fluorophore probes BIOSEARCH TECHNOLOGIES INC 2011-04-27 CN disclosed
EP-2268608-A2 STABILIZED NUCLEIC ACID DARK QUENCHER-FLUOROPHORE PROBES Biosearch Technologies, Inc. (US) 2011-01-05 EP disclosed
US-20090259030-A1 STABILIZED NUCLEIC ACID DARK QUENCHER-FLUOROPHORE PROBES BIOSEARCH TECHNOLOGIES (US) 2009-10-15 US disclosed
WO-2009124150-A2 STABILIZED NUCLEIC ACID DARK QUENCHER-FLUOROPHORE PROBES BIOSEARCH TECHNOLOGIES, INC. (US) 2009-10-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090259030-A1 STABILIZED NUCLEIC ACID DARK QUENCHER-FLUOROPHORE PROBES DDX1, DDX18, DDX3X ALDH1A1 1107/4885LMNA 417/4885OR51E2 1305/4885
US-20110282041-A1 STABILIZED NUCLEIC ACID DARK QUENCHER-FLUOROPHORE PROBES DDX1, DDX18, DDX3X ALDH1A1 1107/4885LMNA 417/4885OR51E2 1305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.